Q10 and Cetamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Q10 (coenzyme q - 10) and Cetamide (sulfacetamide sodium). Common drug interactions include nausea among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Q10 and Cetamide. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Q10?

Q10 has active ingredients of coenzyme q - 10. eHealthMe is studying from 34,261 Q10 users. Check the latest studies of Q10.

What is Cetamide?

Cetamide has active ingredients of sulfacetamide sodium. eHealthMe is studying from 1,053 Cetamide users. Check the latest studies of Cetamide.

On Aug, 11, 2026

17 people who take Q10 and Cetamide together, and have interactions are studied.

What are the common drug interactions of Q10 and Cetamide, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Abdominal discomfort
Blood glucose increased
Fall
Glycosylated haemoglobin increased
Haematochezia (passage of stools containing blood)
Headache (pain in head)
Intervertebral disc compression (spinal disc compression)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pain

male:

Chronic kidney disease
Diarrhoea
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Insomnia (sleeplessness)
Nephrogenic anaemia (anaemia due to kidney disease)
Rash
Renal failure (kidney dysfunction)

What are the common drug interactions of Q10 and Cetamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Epistaxis (bleed from the nose)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)

50-59:

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Anorectal disorder
Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)
Dyspnoea (difficult or laboured respiration)
Mycobacterium avium complex infection
Nausea (feeling of having an urge to vomit)

60+:

Rash
Acne (skin problems that cause pimples)
Chronic kidney disease
Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)
Fatigue (feeling of tiredness)
Gait disturbance
Glossitis (infection of tongue with soreness)
Gout (uric acid crystals building up in the body)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

What are the existing conditions these people have? *

Pain: 5 people, 29.41%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 4 people, 23.53%
High Blood Pressure: 3 people, 17.65%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 17.65%
Cystic Fibrosis (disease of the secretary glands): 2 people, 11.76%
Inflammation: 2 people, 11.76%
High Blood Cholesterol: 2 people, 11.76%
Parkinson's Disease: 2 people, 11.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
Bone Disorder: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Q10 and Cetamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously